Examining the Economic Growth Impact on Cancer Research in India: Disparities Identified
Economic Growth and Cancer Research Inequality
Economic growth impact on cancer research has highlighted troubling disparities in India since 2001, according to a new study. Despite experiencing significant economic advancements, India's clinical trials concerning cancer have not seen consistent growth. Researchers assert that while clinical trials are surging in low and middle-income countries, India remains a case study of inconsistency.
Insights from the Study
- Latin American Cooperative Oncology Group highlighted the disproportionate concentration of cancer trials in high-income nations.
- Data from the World Bank and ClinicalTrials.gov reveal a total of 16,977 cancer trials registered in LMICs between 2001 and 2020.
- India had only 54 clinical trials registered between 2001 and 2005, which increased to 126 during 2016-2020, totaling 506 trials throughout the study period.
Future Considerations
The findings emphasize a critical need for initiatives to support cancer research in LMICs. As senior author Max S. Mano notes, the study's insights could guide future research endeavors to bridge the gap in clinical trial development among these regions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.